CD14 antigen
| GO Term | Evidence Code | PMID |
|---|---|---|
| positive regulation of cytokine production | ||
| positive regulation of cytokine production | ||
| response to molecule of bacterial origin | ||
| cell surface pattern recognition receptor signaling pathway | ||
| receptor-mediated endocytosis |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular space | ||
| extracellular space | ||
| Golgi apparatus | ||
| Golgi apparatus | ||
| plasma membrane |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| lipopolysaccharide binding | ||
| lipopolysaccharide binding | ||
| lipopolysaccharide immune receptor activity | ||
| lipopolysaccharide immune receptor activity | ||
| lipoteichoic acid binding |
| Gene Ontology |
|---|
| cellular response to lipopolysaccharide |
| lipopolysaccharide binding |
| toll-like receptor 4 signaling pathway |
| InterPro |
|---|
| Leucine-rich repeat domain superfamily |
| Leucine-rich repeat, typical subtype |
| Leucine-rich repeat |
| Monocyte differentiation antigen CD14 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026